4: sales network
Already partnering with the largest stroke treatment provider ($11 billion USD revenue ) . They see value in partnering with Nico because more identification of clots leads to more surgeries and more sale of their products. Also, large players such as Siemens, Toshiba would be open to reselling Nico as an add on. Considering the size of the hospital sector, potential is huge .
- Forums
- IPOs
- Nico.lab Pre IPO
4: sales network Already partnering with the largest stroke...
Featured News
Featured News
The Watchlist
RML
RESOLUTION MINERALS LTD
Craig Lindsay, In-Country CEO
Craig Lindsay
In-Country CEO
SPONSORED BY The Market Online